Efrat Lev-Lehman

2.2k total citations
14 papers, 1.2k citations indexed

About

Efrat Lev-Lehman is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Efrat Lev-Lehman has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pharmacology and 5 papers in Computational Theory and Mathematics. Recurrent topics in Efrat Lev-Lehman's work include Cholinesterase and Neurodegenerative Diseases (11 papers), Computational Drug Discovery Methods (5 papers) and Genetic Syndromes and Imprinting (3 papers). Efrat Lev-Lehman is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (11 papers), Computational Drug Discovery Methods (5 papers) and Genetic Syndromes and Imprinting (3 papers). Efrat Lev-Lehman collaborates with scholars based in Israel, United States and Germany. Efrat Lev-Lehman's co-authors include Hermona Soreq, Zafar Nawaz, David M. Lonard, Sophia Y. Tsai, Carolyn L. Smith, Bert W. O’Malley, Ming‐Jer Tsai, Dalia Ginzberg, Yong-hui Jiang and Ting‐Fen Tsai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Molecular and Cellular Biology.

In The Last Decade

Efrat Lev-Lehman

14 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Efrat Lev-Lehman Israel	11	812	481	423	251	121	14	1.2k
Hiroshi Tanahashi Japan	18	626 0.8×	151 0.3×	130 0.3×	77 0.3×	199 1.6×	31	1.1k
Yvonne Nilsson Sweden	5	685 0.8×	158 0.3×	536 1.3×	154 0.6×	155 1.3×	6	1.4k
Joshua O. Scheys United States	15	722 0.9×	84 0.2×	500 1.2×	18 0.1×	132 1.1×	19	1.3k
Qiuxia Zhang China	18	636 0.8×	88 0.2×	374 0.9×	35 0.1×	62 0.5×	38	1.2k
Kerri J. Kinghorn United Kingdom	17	604 0.7×	153 0.3×	64 0.2×	56 0.2×	187 1.5×	23	1.4k
Viyada Nunbhakdi‐Craig United States	12	1.0k 1.3×	102 0.2×	107 0.3×	27 0.1×	236 2.0×	12	1.7k
Roland Pfeiffer Germany	5	557 0.7×	209 0.4×	39 0.1×	117 0.5×	185 1.5×	8	1.2k
Heather Boux United States	12	599 0.7×	264 0.5×	46 0.1×	73 0.3×	251 2.1×	19	1.2k
Suzanne J. Randle United Kingdom	14	639 0.8×	132 0.3×	82 0.2×	77 0.3×	162 1.3×	20	1.1k
Sharon Little United States	6	368 0.5×	173 0.4×	60 0.1×	119 0.5×	163 1.3×	7	847

Countries citing papers authored by Efrat Lev-Lehman

Since Specialization

Citations

This map shows the geographic impact of Efrat Lev-Lehman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efrat Lev-Lehman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efrat Lev-Lehman more than expected).

Fields of papers citing papers by Efrat Lev-Lehman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efrat Lev-Lehman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efrat Lev-Lehman. The network helps show where Efrat Lev-Lehman may publish in the future.

Co-authorship network of co-authors of Efrat Lev-Lehman

This figure shows the co-authorship network connecting the top 25 collaborators of Efrat Lev-Lehman. A scholar is included among the top collaborators of Efrat Lev-Lehman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efrat Lev-Lehman. Efrat Lev-Lehman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Lev-Lehman, Efrat, Ron S. Broide, Eran Meshorer, et al.. (2000). Synaptogenesis and Myopathy Under Acetylcholinesterase Overexpression. Journal of Molecular Neuroscience. 14(1-2). 93–106. 34 indexed citations

2.

Jiang, Yong-hui, Efrat Lev-Lehman, Jan Bressler, Ting‐Fen Tsai, & Arthur L. Beaudet. (1999). Genetics of Angelman Syndrome. The American Journal of Human Genetics. 65(1). 1–6. 146 indexed citations

3.

Grisaru, Dan, Efrat Lev-Lehman, Michal Shapira, et al.. (1999). Human Osteogenesis Involves Differentiation-Dependent Increases in the Morphogenically Active 3′ Alternative Splicing Variant of Acetylcholinesterase. Molecular and Cellular Biology. 19(1). 788–795. 63 indexed citations

4.

Nawaz, Zafar, David M. Lonard, Carolyn L. Smith, et al.. (1999). The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily. Molecular and Cellular Biology. 19(2). 1182–1189. 359 indexed citations

5.

Lev-Lehman, Efrat, Varda Deutsch, Amiram Eldor, & Hermona Soreq. (1997). Immature Human Megakaryocytes Produce Nuclear-Associated Acetylcholinesterase. Blood. 89(10). 3644–3653. 52 indexed citations

6.

Lev-Lehman, Efrat, Varda Deutsch, Amiram Eldor, & Hermona Soreq. (1997). Immature Human Megakaryocytes Produce Nuclear-Associated Acetylcholinesterase. Blood. 89(10). 3644–3653. 2 indexed citations

7.

Andrés, Christian, Rachel Beeri, Alon Friedman, et al.. (1997). Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Iβ gene expression followed by late-onset neuromotor deterioration. Proceedings of the National Academy of Sciences. 94(15). 8173–8178. 58 indexed citations

8.

Beeri, Rachel, Christian Andrés, Efrat Lev-Lehman, et al.. (1995). Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Current Biology. 5(9). 1063–1073. 106 indexed citations

9.

Ariel, I., et al.. (1994). Expression of the imprinted gene H19 in the human fetus. Molecular Reproduction and Development. 38(3). 239–246. 80 indexed citations

10.

Lev-Lehman, Efrat, Avraham Yaron, Mirta Grifman, et al.. (1994). Cholinotoxic effects on acetylcholinesterase gene expression are associated with brain-region specific alterations in G,C-rich transcripts. Brain Research. 661(1-2). 75–82. 7 indexed citations

11.

Patinkin, Deborah, Efrat Lev-Lehman, H Zakut, Fritz Eckstein, & Hermona Soreq. (1994). Antisense inhibition of butyrylcholinesterase gene expression predicts adverse hematopoietic consequences to cholinesterase inhibitors. Cellular and Molecular Neurobiology. 14(5). 459–473. 8 indexed citations

12.

Soreq, Hermona, Deborah Patinkin, Efrat Lev-Lehman, et al.. (1994). Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo.. Proceedings of the National Academy of Sciences. 91(17). 7907–7911. 95 indexed citations

13.

Lev-Lehman, Efrat, Dalia Ginzberg, Gal Ehrlich, et al.. (1994). Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo.. PubMed. 1(2). 127–35. 35 indexed citations

14.

Soreq, Hermona, Catherine A. Prody, Shlomo Seidman, et al.. (1990). Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure.. Proceedings of the National Academy of Sciences. 87(24). 9688–9692. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact